Bullish option flow detected in Crispr Therapeutics with 10,586 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 53.17%. 12/22 weekly 65 calls and Jan-24 55 calls are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.24. Earnings are expected on February 20th.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRSP:
- Crispr Therapeutics positioned for European approval, says Piper Sandler
- Crispr Therapeutics call volume above normal and directionally bullish
- The biopharma stocks to own in 2024, according to Morgan Stanley
- Crispr Therapeutics price target raised by $4 at Morgan Stanley, here’s why
- CRISPR Therapeutics (NASDAQ:CRSP) Tanks after Analyst Downgrade